- Diagnostics
- Wednesday, 19 Feb 2020
Conduent: Disease Surveillance and Outbreak Management System to Fight Coronavirus
Conduent Incorporated (Nasdaq: CNDT) announced a version of its disease surveillance and outbreak management platform, Maven®, to securely track, manage and report on cases of the coronavirus, COVID-19, previously known as 2019-nCoV.
Maven is a software platform developed for organizations, including government agencies, to manage cases of more than 90 communicable diseases. Its flexible design gives organizations the capability to customize disease tracking most prevalent in specific geographies or communities.
Conduent will host the platform's coronavirus-enabled version of Maven in the company's secure cloud so public health agencies and other organizations can get immediate access to use it. Conduent expects its coronavirus module to be available within the month. Additionally, those with advanced training also can leverage the solution's flexibility to customize the Maven platform on their own to track coronavirus.
Based on an organization's need, Maven has the capability to track diseases such as influenza, tuberculosis and Ebola. More than 40 organizations are currently using Maven, and some have already taken advantage of the platform's flexibility by configuring it to track the coronavirus's spread within their respective locations. Conduent is also actively facilitating sharing of best practices between clients as they configure their systems to track the outbreak.
"Maven is a valuable tool that organizations can use to identify and follow up on people who may have come into contact with a person infected with a communicable or infectious disease," said Mark Brewer, President, Global Public Sector Solutions, Conduent. "In the absence of a vaccine, tracking and analyzing who is at risk from contact with an infected person is one of the most important methods available to contain diseases like the coronavirus and prevent widespread outbreaks.
"Maven's technology is scalable and can be quickly and easily configured to changing technologies, protocols and geographic locations — all of which are keys to effective disease outbreak response. It is also designed to allow for easier data sharing and integration among health agencies on the front lines of battling the disease."
Designed with rich contact tracing, outbreak management and detection, state and local health organizations can collaborate to quickly and effectively contain public health crises. Epidemiologists can use Maven's reporting capability to search and analyze the centralized data collected to discover trends and patterns. Maven can also be used to report externally, supporting the need for automatic case reporting to the Centers for Disease Control and Prevention in the United States, the World Health Organization, or local authorities.
Related Industry Updates
Epidemic in the UK is slowing and antibody test could be ready in days, top epidemiologist says
Mar 30, 2020
Almost 9.6 Million Deaths Across the Globe Were Due to Cancer: Who
Oct 04, 2019
ArcherDX Receives Approval for Archer®MET Companion Diagnostic for TEPMETKO® (Tepotinib) in Advanced Non-Small Cell Lung Cancer in Japan
Mar 25, 2020
Dermatologicals Market 2031: Growth Outlook, Key Drivers, and Emerging Opportunities
Nov 20, 2025
UK scientists UK team tests coronavirus vaccine on mice
Feb 13, 2020
Indian Patients to Get Face-to-face Consultations for Coronavirus-2019
Feb 25, 2020
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring (PCM) Assays for Minimal Residual Disease (MRD)
May 26, 2020